Solid oral dosage form comprising a combination of metformin and glibenclamide
US6303146A · kind A · utility
18Cited by
8References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 1999 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | Jul 14, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.